Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

NCT01408030

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +18 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Georgia Regents University Augusta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

NCT00896454

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +77 more
Locations
  • Research Site Encinitas, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Salisbury, Maryland, United States
  • Research Site Dearborn, Michigan, United States
View all 24 locations
View Trial Details
Completed

A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03000452

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • Cancer Center of Central Connecticut Southington, Connecticut, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
View all 25 locations
View Trial Details
Completed

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

NCT00231166

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Dana Farber Cancer Institute StudyCoordinator:CHCD122A2102 Boston, Massachusetts, United States
  • St. Vincent's Comprehensive Cancer Center Dept. of St. Vincent's Cancer New York, United States
  • Oregon Health Sciences University Portland, Oregon, United States
  • University of Pennsylvania--Abramson Cancer Center StudyCoordinator:CHCD122A2102 Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions